Piramal Pharma

PPLPHARMA27 May 2024
Pharmaceuticals
+2.35 (+1.59%)
Lowest Today
Highest Today
Prev. Close
Today’s Open
52 Week High
52 Week Low
To Invest in Piramal Pharma
Piramal Pharma
Pharmaceuticals
PPLPHARMA27 May 2024
+2.35 (+1.59%)
OverviewFundamentals
Corporate action
Peer comparison
Income Sheet
Balance sheet
Cash flow
Share holding
About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.
Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Piramal Pharma Ltd
₹149.80(+2.35/1.59%)
149.80+2.3519,817.7686.6250.612.95
Astrazeneca Pharma India Ltd
₹6,441.05(+429.30/7.14%)
6,441.05+429.3016,102.6398.00100.9624.59
Cipla Ltd
₹1,478.35(-6.95/-0.47%)
1,478.35-6.95119,361.2454.7032.144.27
Bliss GVS Pharma Ltd
₹105.35(-1.55/-1.45%)
105.35-1.551,102.9244.5114.551.12
Abbott India Ltd
₹26,245.10(+25.95/0.10%)
26,245.10+25.9555,770.8419.9846.4315.08
Amrutanjan Health Care Ltd
₹695.30(-12.90/-1.82%)
695.30-12.902,010.1616.0744.696.97

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.
Promoter Shareholding
35.02%
FII Shareholding
30.59%
DII Shareholding
12.13%
Public Shareholding
21.89%
**Promoter pledged shareholding  35.02%

About Piramal Pharma Ltd

Piramal Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 19817.76 crores. It has reported a sales of Rs. 1525.3 crores and a net profit of Rs. 273.08 crores for the quarter ended December 2018. The company management includes Nandini Piramal, Nandini Piramal,PETER D DEYOUNG,Neeraj Bharadwaj,Jairaj Purandare,S Rama Dorai,Peter Stevenson,Sridhar Gorthi,Vibha Paul Rishi,Nathalie Leitch,Vivek Valsaraj,Tanya D'Costa (Piramal Pharma Ltd) among others.
Chairman
Nandini Piramal
Registered office
Ground Floor Piramal Ananta,Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra,400070
FAX :91-22-3802 3884
Background
Incorporation Year2020
Face Value₹10
Market Lot1

How to buy Piramal Pharma shares on nse?

To buy Piramal Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Piramal Pharma share price today?

The Piramal Pharma shares price on nse is Rs.149.8 today.

What is the market cap of Piramal Pharma shares on BSE ?

The company has a market capitalization of Rs.19817.76Cr

What is the PE & PB ratio of Piramal Pharma shares ?

PE is 50.61 and PB is 2.95

What is the 52 Week High and Low of Piramal Pharma shares?

Piramal Pharma stock price high: Rs.166.6 Piramal Pharma stock price low: Rs.78.86

What can be the future price of Piramal Pharma shares on BSE?

The current price of Piramal Pharma on BSE is 71.51 (24 March 2023, 3:25 PM).

The future price of any shares on BSE, including those of Piramal shares are based on a variety of factors and these may lead to changes in the price of a stock at any time. The following factors must be considered while thinking of the future price of Piramal Pharma stocks: 

  • The position of the company in the pharmaceutical industry
  • Innovations of the company
  • Financial and overall company performance
  • Macroeconomic factors
  • Demand for pharmaceuticals
  • Competition

Is it safe to buy Piramal Pharma?

Piramal Pharma, a pharmaceutical company and part of the erstwhile Piramal Group, is a global business with a focus on providing innovative/integrated solutions across the total drug development and manufacturing value chain, right from drug discovery to the commercialisation of medicines. 

Whether a stock is safe to buy or not should be based on many factors like the financials of the company, the competition, the position of the company in the industry, macroeconomic factors and more. 

Nonetheless, the net sales of Piramal Pharma were at Rs. 6559 crores in March 2022, and the net profit was at Rs. 376 crores.

 

What is the current market value per shares of Piramal Pharma?

The current price of Piramal Pharma on BSE is 71.51 (24 April 2023, 3:25 PM).

Does Piramal Pharma have any debts?

As of 24 April 2023, Piramal Pharma has debt amounting to Rs. 5016 crores. 

Will Piramal Pharma shares price increase?

The ROI on Piramal Pharma stock is -65.32% (YTD). 

Determining whether share prices will increase depends on many factors like macroeconomic factors, the company’s performance, trends in the industry, the competition and other variables that influence stock prices frequently, besides on a long-term basis.

 

Should I buy or sell Piramal Pharma?

The 3-month returns on investment (ROI) of Piramal Pharma stock is -35.62%, and YTD is at -65.32%. 

Given this data, any stock’s movement depends on several factors which include: 

  • Company performance
  • Industry trends
  • Market trends
  • Competition
  • Demand and supply
  • Macroeconomic trends